PolyPeptide Group AG Financial Flexibility Index
PolyPeptide Group AG financial flexibility index. PolyPeptide Group AG (PPGN) has a Financial Flexibility Index of 0.22x as of June 2025. Free cash flow of CHF98.34 Million (operating CF CHF49.66 Million minus capex CHF48.68 Million) represents 0% of total liabilities (CHF442.08 Million). Explore PolyPeptide Group AG (PPGN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PolyPeptide Group AG (2018–2024)
Financial flexibility index of PolyPeptide Group AG from 2018 to 2024. Historical Financial Flexibility Index trend for PolyPeptide Group AG across 7 annual periods. Check PPGN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
PolyPeptide Group AG Financial Flexibility Index by Year (2018–2024)
PolyPeptide Group AG financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for PolyPeptide Group AG. For the full cash flow conversion analysis, see PolyPeptide Group AG (PPGN) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | CHF176.37 Million | CHF89.40 Million | CHF399.33 Million | ▲ +45.9% |
| 2023 | 0.30x | CHF93.22 Million | CHF36.48 Million | CHF307.86 Million | ▼ -44.6% |
| 2022 | 0.55x | CHF84.22 Million | CHF5.46 Million | CHF154.10 Million | ▼ -29.6% |
| 2021 | 0.78x | CHF135.06 Million | CHF57.35 Million | CHF173.87 Million | ▲ +71.0% |
| 2020 | 0.45x | CHF90.10 Million | CHF49.48 Million | CHF198.31 Million | ▼ -6.0% |
| 2019 | 0.48x | CHF75.31 Million | CHF55.60 Million | CHF155.73 Million | ▲ +59.6% |
| 2018 | 0.30x | CHF41.24 Million | CHF22.94 Million | CHF136.15 Million | — |